Welcome to our dedicated page for Axcelis Technologies news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Technologies stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
Axcelis Technologies, a key supplier of ion implantation solutions in the semiconductor sector, will participate in the Susquehanna Financial Group 11th Annual Technology Conference on March 3-4, 2022. Key executives including Mary Puma, Kevin Brewer, and Doug Lawson will attend.
The company plans to conduct one-on-one and small group meetings with potential investors on March 3rd. For more details, interested parties can contact a Susquehanna representative.
Axcelis Technologies (Nasdaq: ACLS) announced multiple shipments of its Purion H200™, Purion EXE™, and Purion M™ implanters to prominent Si and SiC power device manufacturers. These deliveries are set for the first quarter, aimed at enhancing high-volume production across various fabs in Europe and Asia. Executive VP Bill Bintz stated that the Purion Power Series product line is uniquely designed for the intensive needs of the power device sector, promising improved device performance and manufacturing capacity.
Axcelis Technologies (Nasdaq: ACLS) announced the election of Dipti Vachani and Jeanne Quirk to its Board of Directors on February 23, 2022. Vachani brings over 25 years of semiconductor industry experience, currently serving as Senior VP at Arm Limited, while Quirk has 30 years of experience in high technology and finance, serving as SVP of Mergers and Acquisitions at TE Connectivity. CEO Mary G. Puma expressed confidence in their contributions towards Axcelis's profitable growth.
Axcelis Technologies (Nasdaq: ACLS) reported record financial results for 2021, achieving revenue of $662.4 million, a 40% increase from 2020. Operating profit reached $127.3 million, marking a 120% growth. The fourth quarter's revenue was $205.7 million, above guidance, with a gross margin of 43.5%. Net income for 2021 was $98.7 million ($2.88 per diluted share). Additionally, the company expects first-quarter revenues of approximately $193 million with a gross margin around 43%. CEO Mary Puma emphasized strong demand and a projected revenue model of $850 million for 2022.
Axcelis Technologies (Nasdaq: ACLS) will showcase its advanced ion implanters at SEMICON Korea 2022, taking place from February 9-11 in Seoul. The company highlights its Purion H™ and XE™ series, designed for high current and energy implant applications. Additionally, Axcelis announces the first shipment from its new Asia Operations Center in Korea, enhancing its capacity to meet growing demand in the Asia Pacific region. President and CEO Mary Puma emphasized their commitment to supporting Korean chipmakers with innovative technologies.
Axcelis Technologies (Nasdaq: ACLS) announced on Feb. 1, 2022, the successful closure of a Purion Dragon™ high current evaluation tool at a leading memory manufacturer. This evaluation, completed in Q4 2021, qualifies the Purion Dragon for high-volume production of DRAM and NAND devices. The executive team expressed optimism about potential follow-on orders in 2022, highlighting the tool's ability to enhance productivity and process control in advanced memory and logic applications.
Axcelis Technologies (Nasdaq: ACLS) will release its Q4 and FY 2021 financial results on February 7, 2022, at 4:00 p.m. ET. A conference call to discuss the results will follow at 5:00 p.m. ET, accessible via an audio webcast on the Axcelis website. Interested investors can dial in using 866.588.8911 (or 707.294.1561 internationally). Axcelis, based in Beverly, Mass., specializes in ion implantation systems for the semiconductor industry.
Axcelis Technologies (Nasdaq: ACLS) announced the shipment of multiple Purion M medium current implanters and a new evaluation tool to memory device makers. These shipments occurred in Q4 2021 and Q1 2022, showcasing strong demand for the Purion M platform. Executive VP Bill Bintz highlighted the platform's flexibility and continued strength in the memory and mature process technology markets as key growth drivers for 2022.
Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of the Purion H200 SiC Power Series™ high current implanters to a major power device chipmaker in Asia and Europe during Q3 and Q4. Additionally, the company closed a Purion XE Power Series SiC high energy implanter evaluation for a new European customer. These systems will aid in high-volume production of SiC power devices for the automotive market. The SiC power device market is projected to grow at a 30% CAGR from 2019 to 2025, indicating strong demand for advanced semiconductor solutions.
Axcelis Technologies (Nasdaq: ACLS) announced its participation in the 24th Annual Needham Virtual Growth Conference from January 10-14, 2022. Key executives, including Mary Puma and Kevin Brewer, will host a fireside chat on January 11 at 1:15 p.m. EST, with one-on-one meetings available. A live webcast of the presentation will be accessible via Axcelis' website and will be available for replay for 30 days post-event. This engagement highlights Axcelis' ongoing contributions to the semiconductor industry.
FAQ
What is the current stock price of Axcelis Technologies (ACLS)?
What is the market cap of Axcelis Technologies (ACLS)?
What does Axcelis Technologies Inc. specialize in?
What are the key products of Axcelis Technologies?
How does Axcelis support its products post-sale?
Where is Axcelis Technologies headquartered?
What financial achievements did Axcelis report for 2023?
What is the significance of the Purion Power Series™?
How does Axcelis collaborate with the semiconductor industry?
What recent strategic moves has Axcelis made?
What upcoming events is Axcelis participating in?
What is the future outlook for Axcelis Technologies?
